Lung function, pharmacokinetics, and tolerability of indacaterol maleate and acetate in asthma patients
D. Miller (North Dartmouth, United States of America), J. Jauernig (Basel, Switzerland), S. Vaidya (Cambridge, United States of America), B. Ethell (Cambridge, United States of America), K. Wagner (East Hannover, United States of America), R. Radhakrishnan (Hyderabad, India), H. Tillmann (Basel, Switzerland)
Source: International Congress 2019 – Clinical studies of asthma treatments
Session: Clinical studies of asthma treatments
Session type: Thematic Poster
Number: 2542
Disease area: Airway diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Miller (North Dartmouth, United States of America), J. Jauernig (Basel, Switzerland), S. Vaidya (Cambridge, United States of America), B. Ethell (Cambridge, United States of America), K. Wagner (East Hannover, United States of America), R. Radhakrishnan (Hyderabad, India), H. Tillmann (Basel, Switzerland). Lung function, pharmacokinetics, and tolerability of indacaterol maleate and acetate in asthma patients. 2542
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: